| Bryna Nicole Criswell, PHARMD | |
|
210 E Broadway, Glenwood, AR 71943-9243 | |
| (870) 356-2193 | |
| (870) 356-3145 |
| Full Name | Bryna Nicole Criswell |
|---|---|
| Gender | Female |
| Speciality | Pharmacist |
| Location | 210 E Broadway, Glenwood, Arkansas |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1881283737 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | PD11676 (Arkansas) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Bryna Nicole Criswell, PHARMD 210 E Broadway, Glenwood, AR 71943-9243 Ph: (870) 356-2193 | Bryna Nicole Criswell, PHARMD 210 E Broadway, Glenwood, AR 71943-9243 Ph: (870) 356-2193 |
News Archive
Why is severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent of COVID-19 (coronavirus disease 2019), biased towards infecting the aged population? A recently published study by Italian scientists linked aging, DNA damage, telomere shortening, and increased levels of angiotensin-converting enzyme 2 (ACE2) to this relationship.
Together with child and adolescent psychiatrists, researchers from the University of Copenhagen have just completed an extensive report which reviews the studies which have been done so far on the significance of diet for children and young people with ADHD. The report shows that there are potential benefits in changing the diets of children with ADHD, but that key knowledge in the area is still lacking.
A multi-institutional team led by investigators from Memorial Sloan-Kettering Cancer Center has published a study that provides new insight into genetic changes that make some forms of glioblastoma, the most common type of primary brain cancer, more aggressive than others and explains why they may not respond to certain therapies.
The amount of time a blood sample used for medical research has been stored at a biobank may affect the test results as much as the blood sample provider's age.
Meda announced today positive results from a Phase III clinical trial of Dymista, a novel formulation of azelastine hydrochloride and fluticasone propionate, in patients with seasonal allergic rhinitis.
› Verified 8 days ago
Edward James Donnelly Sr., RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 253 Highway 70 E Ste A, Glenwood, AR 71943 Phone: 870-356-7445 Fax: 870-356-3299 | |
Kyle F Harvey, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 408 N 1st St, Glenwood, AR 71943 Phone: 870-356-2288 | |
Laiken Hope Sorrells, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 408 N 1st St, Glenwood, AR 71943 Phone: 870-356-2288 |